The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources ...
A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...
The Food and Drug Administration has approved the first at-home test to detect both flu and COVID. The test uses a nasal swab ...
By Melissa Patrick Kentucky Health News Even though the effectiveness of the influenza vaccine was lower in South America ...
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...
A federal court has entered into a consent decree with Rizo Lopez Foods Inc. regarding a deadly Listeria outbreak traced to its cheeses. The U.S. District ...
The Food and Drug Administration has upgraded an ongoing egg recall alert to Class I, meaning the recalled product "will ...
Two recent studies indicate that Nuplazid (pimavanserin) is safe and tolerated well in older or frail adults who experience ...
The U.S. health regulator has declined to approve Zealand Pharma's drug to prevent and treat low blood sugar in children with ...
As of September 6, the FDA and the CDC have reported 65 infections, 24 hospitalizations, and zero deaths linked to the recall ...
The FDA and the CDC worked with states and local partners to investigate a listeria outbreak that killed two, sickened dozens ...